Cemivameran

Comirnaty KP.2 30 microgram/dosis dispersie voor injectie

Dispersie voor injectieNetherlandsAuthorisedAuthorised 21 Dec 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ComirnatyEuropean UnionAuthorised

Comirnaty KP.2 10 Microgramos/Dosis Dispersion InyectableSpain · 10 µg · dispersión inyectable · Biontech Manufacturing GmbhSame brand
Comirnaty KP.2 30 Microgramos/Dosis Dispersion InyectableSpain · 30 µg · dispersión inyectable · Biontech Manufacturing GmbhSame brand
Comirnaty KP.2 3 Microgramos/Dosis Concentrado Para Dispersion InyectableSpain · 3 µg · concentrado para dispersion inyectable · Biontech Manufacturing GmbhSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cemivameran

Comirnaty KP.2 30 microgram/dosis dispersie voor injectie

Dispersie voor injectieNetherlandsAuthorisedAuthorised 21 Dec 2020

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

ComirnatyEuropean UnionAuthorised

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Summary of product characteristicsCBG-MEB

Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Cemivameran
Dosage form: Dispersie voor injectie
Route: Intramusculair gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 21 Dec 2020
Registration: EU/1/20/1528
Marketing authorisation holder: BioNTech Manufacturing GmbH
ATC code: J07BN01
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/005735
EU number: EU/1/20/1528

Netherlands